Epidermal growth factor (EGF) stimulation of cell cycle progression in cultured primary hepatocytes has previously been reported to be dependent on the mammalian target of rapamycin (mTOR) elements of the phosphoinositide 3-kinase (PI3K) signaling cascade and not the Akt pathway. Here we have established conditions of combined treatment of rat hepatocytes with insulin and EGF that favor cell cycle progression. The resulting cell population expresses albumin and retains receptor regulation of the signaling pathways leading to glycogen phosphorylase activation. We then investigated the hypothesis that the Akt limb of the PI3K pathway plays a central role in this insulin/EGF enhancement of cell cycle progression. The phosphorylation of Akt, central to the PI3K pathway, was increased by both insulin (sustained) and EGF (transient). The stimulation of Akt phosphorylation was inhibited in a concentration-dependent manner by the PI3K inhibitor, 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one (LY294002). Cell cycle progression in these cultures was reduced, but not abolished, by this inhibitor. The mTOR inhibitor, rapamycin, also inhibited entry into S phase. The novel Akt inhibitor A-443654
4H-1-benzopyran-4-one (LY294002). Cell cycle progression in these cultures was reduced, but not abolished, by this inhibitor. The mTOR inhibitor, rapamycin, also inhibited entry into S phase. The novel Akt inhibitor A-443654 [(S)-1-(1H-indol-3-ylmethyl)-2-[5-(3-methyl-1H-indazol-5-yl)-pyridin-3-yloxy]-ethylamine] blocked both EGF-stimulated cell cycle progression and phosphorylation of the Akt substrate glycogen synthase kinase-3. Infection of cells with an adenoviral vector expressing a constitutively active form of Akt but not a kinasedead form increased hepatocyte proliferation probably through enhanced cell cycle progression and reduced apoptosis. These results show that the Akt element of the PI3K cascade is necessary for EGF-stimulated cell cycle progression and provide evidence that the sustained elevation of Akt alone generates a hyperproliferative window in hepatocyte cultures.
There is an enormous potential for the development of diverse cell therapies based on hepatocytes, including hepatocyte transplantation. However, the realization of this potential has been hampered by the limited availability of human hepatocytes that are suitable for clinical use. The expansion of hepatocyte populations in culture may, however, offer a solution. The restoration of liver mass and function after repeated partial hepatectomy demonstrates the ability of mature hepatocytes to proliferate without loss of function (Overturf et al., 1997) . Currently, however, only limited proliferation and retention of function of primary human or rat hepatocytes in culture has been achieved on stimulation with growth factors (Loyer et al., 1996; Hino et al., 1999; Runge et al., 1999 Runge et al., , 2000a Katsura et al., 2002; Paine and Andreakos, 2004; Serandour et al., 2005; Yamasaki et al., 2006) . The extent of this proliferation is insufficient to produce large enough populations of fully functional hepatocytes to be used therapeutically. An increased understanding of how growth factor receptors on the cell surface signal toward the nucleus to control cell cycle progression in hepatocytes is therefore of obvious importance. Here, we have studied stimulation with insulin and EGF under conditions that maximize rapid entry of rat hepatocytes into the cell cycle.
Hepatocytes are highly differentiated, multifunctional parenchymal cells. The retention of hepatocyte characteristics is a requirement of the proliferated cells. One unique and highly regulated function of hepatocytes is to store glucose in the form of glycogen and to release it into the bloodstream when required. This release is controlled by glycogen phosphorylase, the activation of which is under dual control by Ca 2ϩ and cyclic AMP signaling pathways. Here we have examined proliferating cultures of rat hepatocytes for evidence that these crucial signaling pathways remain fully functional and that coupling to the activation of glycogen phosphorylase remains intact.
It has been shown that stimulation of hepatocytes with insulin and EGF leads to activation of Akt through PI3K (Band et al., 1999; Roberts et al., 2000; Coutant et al., 2002; Ribaux et al., 2002; Thoresen et al., 2003; Schulze-Bergkamen et al., 2004) . Activation of this signaling pathway is known to play a role in restoration of liver mass after partial hepatectomy (Haga et al., 2005) . The mTOR pathway is also downstream of PI3K and can be activated either independently of Akt or directly by insulin-activated Akt (Nave et al., 1999) . Inhibition of mTOR with rapamycin attenuates hepatocyte responses to insulin and EGF (Francavilla et al., 1992; Band et al., 1999; Coutant et al., 2002; Kim et al., 2006) . However, it has also been reported that attenuation of the Akt component of the PI3K cascade in hepatocytes, by expression of dominant-negative Akt, does not inhibit EGFstimulated DNA synthesis (Coutant et al., 2002) . This finding has led to the suggestion that mTOR, rather than Akt, regulates the proliferative responses in hepatocytes. Here we have used the inhibitor of Akt, A-443654 (Luo et al., 2005; Shi et al., 2005) , to investigate directly for the first time the role of Akt in proliferative responses to insulin and EGF in primary hepatocytes. In addition, we have examined the consequences of adenovirus-mediated expression of both dominant-negative, and constitutively active Akt.
Materials and Methods
Cell Preparation and Culture. Hepatocytes were isolated from male Wistar strain rats as described previously and seeded at a density of 1 ϫ 10 5 cells/well in collagen-coated 24-well plates and 6 ϫ 10 5 cells/well in collagen-coated 6-well plates. The medium was William's medium E (WME) supplemented with 10% FCS with or without insulin (as the Sigma ITS cell culture supplement: 10 g/ml insulin, 5.5 g/ml transferrin, and 6.7 ng/ml sodium selenite). After 4 h, medium was replaced with serum-free WME. At 24 h, EGF (20 ng/ml) was added to insulin-treated cells.
[ Immunocytochemistry. Cells were cultured on collagen-coated Thermanox coverslips (Nalge Nunc International (Rochester, NY).
After BrdU incorporation (15 M for the last 4 h of culture), cells were fixed with formalin, permeabilized with methanol, and incubated with rabbit anti-human albumin (Sigma-Aldrich) and monoclonal anti-BrdU antibodies (Calbiochem). After incubation with fluorochrome-conjugated secondary antibodies (Cy5-conjugated donkey anti-rabbit and Cy3-conjugated goat anti-mouse from Jackson ImmunoResearch Laboratories Inc. (West Grove, PA), cells were visualized with a Leica SM2 confocal imaging system (Leica Microsystems, Heidelburg GmbH, Germany). Controls with no primary antibody showed essentially no fluorescence above background autofluorescence.
Western Blots. After the culture times indicated, cells were lysed (20 mM Tris-HCl, 250 mM NaCl, 3 mM EDTA, 3 mM EGTA, 0.5% Triton X-100, 1 mM phenylmethylsulfonyl fluoride, 2 mM sodium orthovanadate, 1 mM ␤-mercaptoethanol, 20 g/ml aprotinin, and 5 g/ml leupeptin, pH 7.6), and proteins were separated on 10% polyacrylamide gels. Blots were probed with anti-phospho Akt (Ser 473 ) or anti-phospho GSK-3, both from Cell Signaling Technology Inc. (Danvers, MA, and visualized using ECL ϩ Plus (Amersham Biosciences UK, Ltd.).
Measurement of [Ca 2؉ ] c . Cells cultured on collagen-coated coverslips were loaded with fura 2/acetoxymethyl ester and imaged for Ca 2ϩ c in a continuous perfusion chamber as described previously (Dixon et al., 2005) . Agonist stimulation was for 30 s. Stock solutions (10 mM) of ATP and UTP were incubated with a regenerating system comprising 10 mM creatine phosphate and 20 U/ml creatine phosphokinase. UDP was treated with 80 U/ml hexokinase and 110 mM glucose.
Glycogen Phosphorylase and Total [ 3 H]InsP x . Cells were cultured in six-well plates and assayed for glycogen phosphorylase activity as described previously (Dixon et al., 2005 ). For total [
3 H]InsP x , cells were cultured in 24-well plates for 4 h and then labeled for 44 h with myo- [2- 3 H]inositol in serum-free WME (0.185 Mbq/ml, 0.5 ml/well). Twenty-minute stimulations in the presence of 10 mM LiCl were performed without change of medium. Total [ 3 H]InsP x was extracted as described (Dixon et al., 2005) .
Adenoviral Expression of Dominant-Negative Akt and myrAkt. Cells were cultured for 4 h as described. Medium was replaced with serum-free WME containing adenovirus encoding kinase-dead dominant negative (dn) Akt or constitutively active myrAkt. Expression levels resulting from different dilutions of adenovirus were monitored by Western blotting for panAkt to establish a consistent level of Akt expression across the experiments undertaken. These panAkt Western blots showed that expression was apparent at 24 h, maximal at 48 h, and declined thereafter. The adenovirus remained in the cultures, EGF was added where appropriate 20 h later, and [ 3 H]thymidine and MTT assays were completed after a further 24 h. The adenoviral constructs were a kind gift of Dr. R. A. Rippe, University of North Carolina, Chapel Hill, NC.
Data Analysis. Data pooled from separate experiments were collected from different cell preparations and analyzed by one-way ANOVA with Bonferroni's or Dunnett's post-test as indicated, using GraphPad Prism (GraphPad Software Inc., San Diego, CA). 
Results

EGF-Stimulated Entry of Hepatocytes into S Phase
Akt in Hepatocyte Cultures
parison, cultures stimulated with insulin and EGF displayed an increased protein content over the first 48 h to 1.52 Ϯ 0.19-fold higher than controls (mean Ϯ S.E., n ϭ 3 separate experiments). Passage of cells into S phase was also assessed through BrdU incorporation; cells were coimmunostained for albumin to confirm their identity as hepatocytes (Fig. 1C) . After 4 h in culture, essentially all cells stained positively for albumin and revealed no incorporation of BrdU (left panel). After 48 h in culture and addition of EGF at 24 h, there was both an increase in the area occupied per cell and in cell number (typically 1.5-fold by 48 h); hepatocytes staining positively for BrdU could be clearly seen (middle panel). Hepatocytes were occasionally captured with BrdU-stained chromosomes in anaphase (right panel). These experiments established that the conditions used gave reliable stimulation of hepatocytes into S phase.
Receptor-Regulated Events in Insulin/EGF-Treated Hepatocytes. To determine whether the insulin/EGFtreated cells retain characteristics of hepatocytes, we studied the signaling pathways leading to glycogen phosphorylase activation. In previous studies we have characterized increases in [ 3 H]InsP x and [Ca 2ϩ ] c in rat hepatocytes in response to extracellular nucleotides acting through P2Y 1 and P2Y 2 receptors (Dixon, 2000; Dixon et al., 2004 Dixon et al., , 2005 . Here we have shown that accumulation of [ 3 H]InsP x in response to 2-methylthio-ADP (acting through the P2Y 1 receptor) and ATP and UTP (P2Y 2 ) are not significantly different in control and insulin/EGF-treated cells (data not shown). In addition individual cells from these two populations produce indistinguishable rises in [Ca 2ϩ ] c , in terms of both size and concentration dependence, when stimulated by these nucleotides (data not shown). Consistent with these findings, no differences were observed in the activation of glycogen phosphorylase in response to the nucleotides ATP, UTP, 2-methylthio-ADP and UDP in populations of control and proliferating cells (Fig. 2) . Activation of glycogen phosphorylase by glucagon, which is mediated by increased cyclic AMP levels, was also unaltered as seen in Fig. 2 . For both glycogen phosphorylase and [
3 H]InsP x assays, the absolute values per well were higher in the insulin/EGF-treated cultures, reflecting the greater cell content per well (not shown).
Involvement of PI3K/Akt/mTOR in the Proliferative Response. It is known that stimulation of hepatocytes with insulin and EGF leads to activation of Akt through PI3K. This is illustrated in Fig. 3A , which shows that the concentration of insulin that we used to promote cell cycle progression, substantially stimulated Ser 473 phosphorylation of Akt, and this was sustained over 24 h. In contrast, the phosphorylation of Akt in response to 20 ng/ml EGF was transient and peaked at 5 to 10 min; with stimulations longer than 2 h, no phosphorylation was detectable (Fig. 3B) . With insulin present for only the first 4 h of culture, the enhanced phosphorylation persisted at 24 h (Fig. 3C ). When EGF (20 ng/ml) was applied at this point (i.e., replicating the culture conditions used to stimulate entry into S phase), there was a further increase in Akt phosphorylation in each experiment undertaken (Fig. 3C) . This insulin-and EGF-stimulated Akt phosphorylation was inhibited by the PI3K inhibitor, LY294002 in a concentration-dependent manner, with complete inhibition at 10 M (Fig. 3C ).
To determine whether the PI3K cascade is central to the progression of hepatocytes through the cell cycle under the conditions used here, we looked at the effect of inhibitors of PI3K (LY294002), mTOR (rapamycin), and Akt (A-443654) on [
3 H]thymidine incorporation measured at 48 h. The enhancement of [ 3 H]thymidine incorporation by a 4-h insulin treatment was reduced by the presence of 10 M LY294002 (Fig. 4A) or 3 nM rapamycin (Fig. 4B) over this period. The inclusion of rapamycin led to a decrease in [
3 H]thymidine incorporation in control cells. As seen in Fig. 4, A and B , a substantial residual response to insulin remained in the presence of the inhibitors, even at a concentration of LY294002 (10 M) that abolishes Akt phosphorylation (Fig.  3C) . In further experiments, the effect of LY294002 and rapamycin on EGF-stimulated cell cycle progression was investigated by adding the inhibitors together with EGF after 24 h in culture and measuring [ 3 H]thymidine incorporation after a further 24 h. Consistent with earlier reports (Band et al., 1999; Coutant et al., 2002) , both drugs blocked stimulation of DNA synthesis by EGF (data not shown). For LY294002 this inhibition showed a dose dependence similar to that for inhibition of EGF-stimulated Akt phosphorylation; [ 3 H]thymidine incorporation in response to 20 ng/ml EGF was reduced to 23.9 Ϯ 5.2% by 5 M LY294002 and to 3.4 Ϯ 1.7% by 20 M LY294002 (mean Ϯ S.E.M., n ϭ 3 separate experiments). Rapamycin (3 nM) completely abolished the response to 20 ng/ml EGF (not shown).
The inclusion of the Akt inhibitor, A-443654 (3 M), during the 4-h incubation with insulin, led to a reduction in [
3 H]thymidine incorporation at 48 h in both control and insulin- Fig. 3 . Stimulation of Akt phosphorylation by insulin and EGF and inhibition by LY294002. A and B, cells were cultured for 24 h and then were stimulated with insulin (10 g/ml) or EGF (20 ng/ml) for the times shown. C, conditions were those used to promote cell cycle progression: insulin was present for the initial 4 h only, EGF was added at 24 h, and the cells were extracted after 5 min. LY294002 (10 M) was added at the concentrations (Conc.) shown 30 min before addition of EGF. Western blots were probed using the antibody for phosphorylated Akt (Ser 273 ) and are representative of three experiments.
Fig. 4. Effects of the inhibitors, LY294002 (LY), rapamycin (Rap), and A-443654 (A443) on [
3 H]thymidine incorporation into DNA and cell viability. For all panels cells were cultured in the presence of inhibitors for 30 min before addition of 10 g/ml insulin where indicated and cultured again for 4 h. Then, cells were cultured in serum-free medium without insulin or inhibitor. Inhibitor concentrations were 10 M LY294002, 3 nM rapamycin, and 3 M A-443654. (Fig. 4C) . To determine whether this reduction was due to cell death, we also measured protein concentrations of cultures and used the MTT assay to assess numbers of viable cells. When measured after 48 h in culture, protein levels (not shown) and cell viability (Fig. 4D) were reduced by inclusion of A-443654 in the initial 4-h culture period. With inhibitor present for 48 h, there was a major loss of both protein and MTT activity, and the cells became rounded and apoptotic (not shown).
The effect of A-443654 on the EGF-mediated stimulation of DNA synthesis was investigated. A-443654 (3 M) was added 30 min before the addition of EGF after 24 h in culture. Cells were then exposed to EGF for 24 h and to A-443654 for varying periods, after which inhibitor was removed and EGF was replaced. EGF significantly stimulated the [ 3 H]thymidine incorporation into DNA 20 to 24 h later. When EGF was added in the presence of A-443654, there was no significant stimulation, even when the A-443654 was only present for the 1st h of the 24-h period of EGF stimulation (Fig. 5A) . Of importance, the 1-h exposure to A-443654 did not lead to significant changes in protein concentration, cell viability (as assessed by MTT assay), or appearance of cells after 24 h (not shown). To investigate whether A-443654 inhibits Akt in these cells, Western blots for phospho-GSK-3, a substrate of the Akt kinase, were performed; Figure 5B shows a representative blot, and Fig. 5C shows densitometric data pooled from four experiments. Both EGF and insulin stimulated the phosphorylation of GSK-3; this was blocked by 3 M A-443654.
Effect of Adenoviral Expression of Dominant-Negative Akt and myrAkt. To further investigate the role of Akt in hepatocyte proliferation we used adenoviral constructs expressing either a kinase-dead dnAkt or a constitutively active form (myrAkt). Figure 6A shows the effect of these constructs on cell viability (MTT assay). EGF typically had little effect. However, as strikingly illustrated in Fig. 6A , the expression of myrAkt led to a substantial increase in the number of viable cells, as assessed by the MTT assay; stimulation of these cells with EGF had no additional impact on cell viability. In contrast, expression of dnAkt had no effect. [ 3 H]Thymidine incorporation into DNA measured at 48 h in cells expressing these constructs is depicted in Fig. 6B 
Discussion
Generating hepatocyte cultures that divide and retain differentiated characteristics is a goal that has eluded researchers. This lack of cultures in turn has hampered the development of cell therapy procedures that could have enormous impact on the treatment of liver diseases, many of which currently necessitate liver transplantation. Increasing our understanding of how cell surface receptors signal toward the nucleus to control cell cycle progression in hepatocytes will 3 H]thymidine incorporation and GSK-3 phosphorylation. A, cells were incubated for 4 h with 10% FCS and 10 g/ml insulin, and then medium was replaced with serum-free WME for 20 h. A-443654 (3 M) was added 30 min before stimulation with EGF (20 ng/ml) and remained with EGF for the time indicated. A-443654 was then removed, and EGF was replaced. [
3 H]thymidine incorporation in EGF-stimulated cells (shaded bars) and control cells (open bars) was measured at 48 h. Data are means Ϯ S.E.M., n ϭ 3 from three separate experiments each performed in quadruplicate. ANOVA followed by Bonferroni's post-test: EGF stimulation was significant in the absence of A-443654 ‫,ءء(‬ P Ͻ 0.01) and not significantly different from control in the presence of inhibitor. B, cells were cultured in WME with 10% FCS but without insulin for 4 h and then in serum-free medium for a further 44 h. Where indicated, cells were incubated with 3 M A-443654 for 30 min before stimulation for 5 min with EGF (20 ng/ml) or insulin (10 g/ml). Cell extracts were then subjected to Western blotting with phospho-GSK-3 antibodies. C, densitometric data from such Western blots, scanned and pooled across four separate experiments. ANOVA followed by Bonferroni's post-test: A-443654 (3 M) significantly reduced the response to EGF ‫,ءءء(‬ P Ͻ 0.001) and insulin ‫,ءء(‬ P Ͻ 0.01). jpet.aspetjournals.org help achieve the aim of producing populations of fully functional hepatocytes for future cell therapy procedures, including hepatocyte transplantation.
In the initial work described above, we have defined culture conditions that stimulate cell cycle progression. The resulting population of cells was assessed for the retention of hepatocyte characteristics through the study of glycogen phosphorylase activation. This key enzyme in glycogenolysis is activated by glucagon mediated by increases in cyclic AMP levels and by extracellular nucleotides, acting via members of the P2Y family of receptors to increase [Ca 2ϩ ] c (Okajima et al., 1987; Keppens et al., 1992 Keppens et al., , 1993 Dixon, 2000; Carini et al., 2006) . The complex pattern of second messenger increases and glycogen phosphorylase activation effected by glucagon and a range of nucleotides acting through multiple P2Y receptors was similar in cells from control cultures and those progressing through the cell cycle.
We then set out to investigate the signaling mechanisms from insulin and EGF receptors that bring about the proliferative response in these hepatocyte cultures. An early report (Band et al., 1999) suggested that the proliferative response to EGF is independent of the activation of extracellular signal-related kinase and that activation of PI3K/Akt/ mTOR is sufficient. However, later evidence (Coutant et al., 2002; Thoresen et al., 2003) indicated that both extracellular signal-related kinase and PI3K pathways are required downstream of the EGF receptor. Furthermore, on the basis of a failure of dominant negative Akt to abrogate EGF-stimulated DNA synthesis, it was concluded that Akt was not directly involved in the cell division stimulated by EGF (Coutant et al., 2002) . This conclusion supported the notion that the PI3K-dependent response is mediated by the mTOR branch of the pathway and not by Akt. With the recent development of a chemical inhibitor of Akt (A-433654) (Luo et al., 2005; Shi et al., 2005) , we decided to further investigate the role of elements of the PI3K/mTOR/Akt pathway in the responses to insulin and EGF, which establish the proliferating cultures described above.
In agreement with earlier work (Coutant et al., 2002; Ribaux et al., 2002; Kim et al., 2006) , we have demonstrated that Akt is phosphorylated in response to EGF and insulin; this phosphorylation was transient in response to EGF (peak at 5-10 min) and sustained (over 24 h) in response to insulin. Interestingly, the inclusion of insulin for only the first 4 h of culture resulted in enhanced phosphorylation of Akt 24 h later when EGF was added. This sustained activation of the PI3K pathway may contribute to the lasting influence of insulin, long after its removal from culture. The insulin and EGF-stimulated phosphorylation of Akt and GSK-3 was eliminated by the inhibition of the PI3K pathway by LY294002. We then showed that LY294002 inhibited insulinstimulated DNA synthesis, confirming the requirement for the PI3K cascade in progression through the cell cycle. Similarly the significance of mTOR in these cultures is clearly demonstrated by the effects of the inhibitor, rapamycin; [ 3 H]thymidine incorporation was reduced in both control and insulin-treated cultures. However, the clear residual response to insulin indicates that although mTOR plays a role in proliferation of hepatocytes, stimulation by insulin is, in part, independent of mTOR.
A-443654 inhibited [ 3 H]thymidine incorporation similarly in both control and insulin-enhanced cultures, at a concentration that we have shown to eliminate agonist-stimulated phosphorylation of the Akt substrate, GSK-3. Down-regulation of Akt has been associated with apoptosis in hepatocytes (Schulze-Bergkamen et al., 2004) . It was therefore important to determine whether the attenuation of [ 3 H]thymidine incorporation could be accounted for by cell death. The measurements of the protein content of cultures and cell viability through the MTT assay were consistent with an increased loss of cells when A-443654 was present during the first 4 h of culture. Overall the initial inhibition of DNA synthesis by 3 H]thymidine incorporation into DNA (B) in control (con) and EGF-stimulated cells. Cells were cultured for 4 h with 10% FCS and 10 g/ml insulin, which was then replaced with serum-free WME containing adenovirus encoding kinasedead dnAkt or constitutively active myrAkt. EGF (20 ng/ml) was added where indicated at 24 h and A-443654, followed by an increasing loss of cells over 48 h, are consistent with a requirement for Akt for both cell cycle progression, and to restrain apoptosis.
The experiments investigating the effect of Akt inhibition on EGF-stimulated cell cycle progression had a clear outcome. When cells were stimulated with EGF for 24 h, A-443654 needed to be present only during the 1st h to have a maximal effect, eliminating EGF-stimulated cell cycle progression. This is consistent with the transient stimulation of Akt by EGF seen here in Western blots. Under these conditions, with A-443654 present for only 1 h, there was no subsequent loss of viable cells over the next 24 h, indicating that the Akt inhibitor did not enhance apoptosis. These results provide a compelling case for an obligatory role for Akt in the stimulation by EGF of cell cycle progression in hepatocytes, independent of the effect that inhibition of this kinase may have on apoptosis. Interestingly, though, we have found that the maximal stimulation of DNA synthesis by the addition of EGF 20 h after plating cells with insulin, requires that EGF be present for Ͼ8 h (Y. Luo and M. R. Boarder, unpublished data). The most likely explanation is that persistent signaling from the EGF receptor through other pathways, such as sustained extracellular signal-related kinase activation (Thoresen et al., 2003) , is required in addition to the transient Akt activation.
The adenoviral-mediated expression studies presented here are consistent with a central role of Akt in EGF-stimulated cell cycle progression. Three notable observations were made. First, the expression of myrAkt led to enhanced [ 3 H]thymidine incorporation, second, the expression of dnAkt reduced the [ 3 H]thymidine incorporation stimulated by EGF, and third, the expression of myrAkt and stimulation with EGF were not additive. Furthermore, it is characteristic of our experiments with EGF stimulation that a substantial [ 3 H]thymidine response was seen with little or no increase in the MTT response, consistent with the cells passing through S phase at this time but not completing proliferation. In contrast, the expression of constitutively active Akt increased both the [ 3 H]thymidine response and the number of viable cells as assessed by the MTT assay. These observations are consistent with cells having completed replication at this time point, 44 h from the start of transfection. Through Western blots we have shown that expression of heterologous Akt protein is apparent at 24 h and increased after 48 h. Our heterologous expression studies suggest that sustained elevation of Akt alone is sufficient to elicit complete transit through the cell cycle. This contrasts with the conclusions for stimulation by EGF described above, for which a transient stimulation of Akt is necessary, but not sufficient, to stimulate cell cycle progression. A reduction in apoptosis as a result of a sustained elevation in Akt activity may also contribute to the enhanced MTT reading with myrAkt treatment.
In conclusion, we have demonstrated that the Akt element of the PI3K cascade is necessary for EGF-stimulated cell cycle progression. The sustained elevation of Akt through adenovirus-mediated Akt expression generates a hyperproliferative window in hepatocyte cultures, increasing the possibility of achieving the goal of producing expanding populations of fully functional hepatocytes for future cell therapy procedures. Further studies will characterize the hepatocyte population after adenovirus-mediated expression of myrAkt.
